Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.656
-0.022 (-3.26%)
At close: Nov 20, 2024, 4:00 PM
0.650
-0.006 (-0.93%)
Pre-market: Nov 21, 2024, 7:41 AM EST
Ensysce Biosciences Employees
Ensysce Biosciences had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$631,629
Profits / Employee
-$1,132,443
Market Cap
12.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 380 |
| Vivos Therapeutics | 123 |
| Cosmos Health | 123 |
| STRATA Skin Sciences | 99 |
| Sol-Gel Technologies | 36 |
| AIM ImmunoTech | 28 |
| Sensei Biotherapeutics | 28 |
| Traws Pharma | 18 |
ENSC News
- 8 days ago - Ensysce Biosciences Reports Third Quarter 2024 Financial Results - Accesswire
- 14 days ago - Ensysce Biosciences Receives Positive Nasdaq Listing Determination - Accesswire
- 6 weeks ago - Ensysce Biosciences Announces Leadership Team's Participation in the Annual Pain Therapeutics Summit - Accesswire
- 7 weeks ago - Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries - Accesswire
- 7 weeks ago - Ensysce Biosciences Receives Notice from Nasdaq - Accesswire
- 2 months ago - Ensysce Biosciences Presenting at Upcoming Meetings - Accesswire
- 2 months ago - Ensysce Biosciences Submits Phase 3 Protocol to the FDA - Accesswire
- 2 months ago - Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024 - Accesswire